Photo of Pam Guzzone
D Maryland House of Delegates · District 13 On the 2026 ballot

Del. Pam Guzzone

Compare
Total votes
5,510
all sessions
Attendance
100%
16 missed
Higher than 95% of chamber peers
With party
99%
of cast votes
Near the chamber average
Bipartisan score
0%
crosses aisle rarely
Near the chamber average
Sponsored
362
bills & resolutions
Higher than 81% of chamber peers
Committees
1
assignment
362 bills and resolutions

Sponsored bills

Total
362
Primary
362
Co-sponsor
0
This page
362
matching current filters
Primary HB 838
Signed into law · Maryland House of Delegates · Lead sponsor
State Board of Pharmacy - Prescriber-Pharmacist Agreements

Maddy summaryHB 838 repeals a requirement that prescribers submit prescriber-pharmacist agreements to their regulating health board. Instead, it allows pharmacists (with specific qualifications, registrations, and training) to directly enter agreements authorizing them to treat opioid use disorder using controlled substances. A key provision requires pharmacists to check the Prescription Drug Monitoring Program (PDMP) for relevant patient data before starting or changing such therapy. This bill directly affects pharmacists, prescribers, and patients with opioid use disorder by expanding pharmacists' role in medication management under defined safeguards.

Signed into law Apr 14, 2026 0 co-sponsors
Primary HB 747
Signed into law · Maryland House of Delegates · Lead sponsor
Oversight Committee on Quality of Care in Nursing Homes and Assisted Living Facilities – Membership

Maddy summaryHB 747 changes the membership structure of Maryland's Oversight Committee on Quality of Care in Nursing Homes and Assisted Living Facilities. The bill reduces the number of House-appointed members from two to one and removes specific agency representatives, while adding three industry representatives from the assisted living sector (categorized by facility size: 1-4, 5-9, and 10+ residents). This committee directly affects nursing homes, assisted living facilities, and their residents by shaping oversight of care quality standards. The bill takes effect October 1, 2026, and modifies existing law without altering the committee's core purpose.

Signed into law Apr 14, 2026 0 co-sponsors
Primary HB 322
Signed into law · Maryland House of Delegates · Lead sponsor
Maryland Health Care Commission - Membership

Maddy summaryHB 322 changes the membership structure of Maryland's Health Care Commission. It reduces the number of non-healthcare-related members from nine to eight and adds a required hospital representative (defined in state law) to the seven provider-focused seats. The bill also revises geographic requirements, mandating four members from large-population counties (instead of five) and specifying representation from the Eastern Shore, western counties, and Southern Maryland. These changes take effect October 1, 2026, aiming to adjust the commission's composition to better reflect healthcare provider perspectives.

Signed into law Apr 14, 2026 0 co-sponsors
Primary HB 7
Signed into law · Maryland House of Delegates · Lead sponsor
State Board of Examiners for Audiologists, Hearing Aid Dispensers, Speech-Language Pathologists, and Music Therapists - Authority to Issue Limited Licenses to Practice Music Therapy

Maddy summaryHB 7 authorizes Maryland's State Board of Examiners to issue limited licenses for music therapists who are completing full licensing requirements but lack sufficient clinical experience. This directly affects new music therapists and healthcare facilities needing to hire them under supervision while they fulfill certification steps. The bill creates a 1-year limited license (renewable once) requiring direct supervision by a fully licensed music therapist, with a 2-year deadline to obtain full licensure. It explicitly states limited licenses cannot replace services from audiologists or speech-language pathologists. The policy change streamlines entry into the profession without altering existing practice standards for music therapy.

Signed into law Apr 14, 2026 0 co-sponsors
Primary HB 442
Signed into law · Maryland House of Delegates · Lead sponsor
Professional Liability Insurance Coverage - Nursing Homes, Assisted Living Facilities, Nurse Midwives, and Licensed Certified Midwives - Disclosure (Nyeli Rose Lewis Act of 2026)

Maddy summaryHB 442 requires nursing homes, assisted living facilities, and nurse midwives in Maryland to disclose their professional liability insurance status to residents and potential residents. Specifically, these providers must provide written notice (including electronic communication) if they lack coverage or if coverage has lapsed and not been renewed, with timing requirements: at the first visit for potential residents or at application for admission, and within 30 days of a lapse for current residents. The bill also mandates that facilities without coverage post a conspicuous notice for residents and guests. This law does not change insurance requirements but ensures transparency about coverage gaps. It directly affects residents and potential residents of these care facilities by providing clear, timely disclosure of insurance status.

Signed into law Apr 14, 2026 0 co-sponsors
Primary HB 637
Signed into law · Maryland House of Delegates · Lead sponsor
Public Health - Recommendations for Immunizations, Screenings, and Preventive Services - Pharmacist Administration and Required Health Insurance Coverage (The Vax Act)

Maddy summaryHB 637 ("The Vax Act") requires Maryland's Secretary of Health to issue science-based recommendations for immunizations, screenings, and preventive services using guidance from major medical organizations like the CDC and American Academy of Pediatrics. It expands pharmacists' authority to administer flu, COVID-19, and emergency vaccines to patients aged 3 and older (previously limited to 18+ for some vaccines) after completing specific training. The bill also mandates that health insurance plans cover these recommended services without cost-sharing for patients. This directly affects pharmacists, health insurers, and Maryland residents seeking preventive care, particularly children and adults needing routine vaccinations.

Signed into law Apr 14, 2026 0 co-sponsors
Primary HB 1445
Passed · Maryland House of Delegates · Lead sponsor
Maryland Medical Assistance Program and Developmental Disabilities Administration - Home- and Community-Based Services Eligibility Determinations (Maryland Protecting People With Disabilities Act)

Maddy summaryHB 1445, the "Maryland Protecting People With Disabilities Act," changes eligibility rules for home- and community-based services under Maryland's Medicaid program (Maryland Medical Assistance Program). It requires the state to continue services uninterrupted during appeals if an individual loses eligibility, prohibits automatic termination solely due to administrative errors (procedural disenrollment), and mandates data sharing between providers and the Department of Health. The bill directly affects people receiving Developmental Disabilities Administration services and Medicaid beneficiaries who risk losing community-based care due to eligibility disputes. Key provisions include extending appeal timelines (replacing 90-day deadlines with continuous service until appeal resolution) and requiring the state to reserve waiver slots for those who lost eligibility unfairly. These changes aim to align with the Olmstead v. L.C. Supreme Court ruling protecting community integration rights.

Passed Apr 13, 2026 0 co-sponsors
Primary HB 1117
Passed · Maryland House of Delegates · Lead sponsor
Virginia I. Jones Alzheimer's Disease and Related Dementias Council and the Advisory Stakeholder Group on Autism-Related Needs - Recommendations for Elopement Response Devices

Maddy summaryHB 1117 requires Maryland's Medicaid program (Maryland Medical Assistance Program) and certain insurers to cover approved "elopement response devices" for specific individuals. These devices - such as door sensors, wearable location trackers, or alert systems - prevent people with cognitive, developmental, or neurological conditions from wandering unsafely (e.g., leaving a supervised area without the ability to return safely). Coverage is mandated when ordered by a qualified healthcare provider and documented in a qualifying plan (like an individualized education plan or dementia care plan) for eligible recipients: those under 21 with early screening eligibility, on home-based waiver programs, or diagnosed with Alzheimer’s/dementia. The bill defines these devices as medical equipment or assistive technology under state programs, ensuring coverage without regard to when the program was established.

Passed Apr 13, 2026 0 co-sponsors
Primary HB 1602
Passed · Maryland House of Delegates · Lead sponsor
Counties - No-Cost Preventive Cancer Screenings for Volunteer and Retired Volunteer Firefighters

Maddy summaryThis bill requires Maryland counties with volunteer fire companies to provide no-cost preventive cancer screenings to volunteer firefighters, as defined by the bill. Volunteer fire companies must maintain and annually submit a list of their volunteer firefighters to the county, which must then keep this list on file. Counties can meet this requirement by either offering a free annual health exam including cancer screenings or applying for a specific grant to fund advanced screening technologies like multi-cancer blood tests. The law applies to all counties with volunteer fire companies and takes effect July 1, 2026.

Passed Apr 13, 2026 0 co-sponsors
Primary HB 1426
Passed · Maryland House of Delegates · Lead sponsor
Clinical Research Pharmacies and Clinical Trials - Permits and Ownership

Maddy summaryHB 1426 creates a new permit for clinical research pharmacies in Maryland, which are facilities specifically designed to conduct clinical trials. It allows healthcare providers to own these pharmacies under strict conditions, including requiring a licensed pharmacist to be on-site during all operating hours and prohibiting owners from receiving payment for patient referrals. The bill also exempts clinical trials conducted by corporations or entities from being classified as "practice of medicine," meaning trial staff no longer need individual medical licenses for their trial-related work. This change aims to streamline clinical research by removing a regulatory barrier that previously required individual licensing for trial staff.

Passed Apr 13, 2026 0 co-sponsors
Showing 51 to 60 of 362 bills
Previous 1 … 5 6 7 … 37 Next